Abstract. We studied 112 patients with malarial acute renal failure (ARF) during the period 1991-1997 at Bangkok Hospital for Tropical Diseases (Mahidol University, Bangkok, Thailand). Hemodialysis was performed in 101 (90.2%) of these patients. The mean number of times the patients were hemodialyzed was 6.5 (range ϭ 1-27). Ninety-three (83.0%) patients were oliguric and the remainder were nonoliguric. Patients who had oliguric renal failure required more hemodialyses and had more complications than the nonoliguric patients. The oliguric patients had an eight-fold higher risk of requiring six or more hemodialyses (95% confidence interval ϭ 1.2-53.9, P ϭ 0.0008). The overall mortality rate was 10.7% (12 of 112). Eleven of the patients who died were jaundiced and eight of them had cerebral malaria with a Glasgow Coma Score Յ 8. We conclude that hemodialysis is a useful treatment for oliguric and nonoliguric ARF from severe malaria, particularly when initiated early in the course of the illness.
Malaria remains one of the world's major health problems, particularly in the tropics. Currently, it affects more than 200 million individuals and 1-2 million people die of the disease each year. 1 Estimates of mortality based only on reported cases probably underestimate the number of deaths.
Acute renal failure (ARF) is one of the three most common causes of death in severe malaria. 2 Before 1980, the mortality rate of patients with severe complicated malaria was 29-40%. 3, 4 Moreover, in cases with lung complications, the mortality rate increased to 60-75%. 3, 5 Since 1980, with early dialysis for renal failure and full respiratory supportive measures, the mortality rate of complicated malaria has decreased to 10-20%, but it still remains at 40% in cases with lung complications. 6 The outcome of severe malaria depends on the time between onset of symptoms and arrival to a health facility and on the available facility resources and health worker capacity to manage the complications. 7 Most severely ill patients live in rural areas endemic for malaria where the facilities are limited.
Malaria caused by Plasmodium falciparum is still one of the most common causes of ARF in adults in those areas of the tropics where transmission of malaria is unstable and where symptomatic disease occurs at all ages. 8 Established ARF is usually oliguric, but may also be polyuric with normal or excessive urine volumes in the presence of increasing serum creatinine values. 8 In most hospitals in malarial endemic areas, conservative management and peritoneal dialysis are the only opportunities for the treatment of malarial ARF. However, hemodialysis can be performed in some hospitals. The aim of this study was to describe the prevalence, clinical signs and symptoms, management, and outcomes in malarial ARF patients admitted to our hospital, 90% of whom were treated with hemodialysis.
SUBJECTS, MATERIALS, AND METHODS
Study subjects. We studied 112 patients with ARF caused by falciparum malaria in a case series over a seven-year period from 1991 to 1997 at the Hospital for Tropical Diseases (Mahidol University, Bangkok, Thailand). Prior to the present illness, all of the patients were healthy and had no renal disorders except that two of them were positive for human immunodeficiency virus (HIV). Most (98) of the patients had malaria for the first time and had contracted the infection at the Thailand-Myanmar border. The study was reviewed and approved by the Ethics Committee of Mahidol University. Informed consent was provided by conscious patients before participating in the study. For comatose patients, relatives provided informed consent.
The definition of ARF was a serum creatinine concentration Ͼ 3 mg/dL (Ͼ 265 mol/L) and/or a 24-hr urine output Ͻ 400ml, despite rehydration, in adult patients who had documented falciparum malaria, i.e., asexual forms of P. falciparum on their peripheral blood smear.
We described systemic complications by using the World Health Organization criteria. 7 Jaundice was defined as icteric sclera and/or total bilirubin levels Ͼ 3 mg/dL (Ͼ 50 mol/ L). Hypoglycemia was defined as venous blood glucose Ͻ 40 mg/dL (Ͻ 2.2 mmol/L). The definition of oliguria was a urine output Ͻ 400 ml/24 hr. Hyperparasitemia was defined as Ͼ 250,000 parasites/l of blood (Ͼ 5% of the erythrocytes parasitized).
We measured the input and output every 8 hr. Total input included intravenous fluid and everything the patient had drunk. Total output included urine, vomitus, blood loss, liquid stool, and ultrafiltrate from the hemodialysis. We prepared blood smears (thick and thin films) every 6 hr during treatment until they were negative and once a day thereafter. Parasite clearance time was the period in hours from the start of drug treatment until the first negative blood film. We measured temperatures every 6 hr. Fever clearance time was the period (in hours) from the start of drug treatment until the oral temperature decreased to 37.5ЊC and remained below this temperature for the next 48 hr.
Treatment. All patients received antimalarial drug therapy. Ninety-three patients were given artemisinin derivatives (artesunate, artemether, or arteether) as part of clinical trials. Nineteen patients received quinine and seven of these were given both artemisinin and quinine. Twenty-one patients received mefloquine at the end of the artemisinin treatment (to prevent recrudescence and increase cure rate).
We managed the ARF patients with fluid replacement, high-dose furosemide, and low-dose dopamine infusion before the first hemodialysis. All hemodialyses were performed without regional heparinization, using a one-coil dialyzer (Drake-Willock, CD Medical, Inc., Portland, OR).
The indications for hemodialysis, as shown in Table 1 , were anuria (24-hr urine output Ͻ 50 ml), volume overload, electrocardiographic evidence of hyperkalemia, metabolic acidosis (arterial pH Ͻ 7.25), uremic syndrome (encephalopathy in a previously conscious recovering patient, gastrointestinal hemorrhage, pericarditis) or a rapidly increasing serum creatinine level Ͼ 3 mg/dL. In very severe cases with many complications, the hemodialysis was started at lower creatinine levels. Urethral catheters were inserted in all patients, and an accurate record was kept of fluid balance. Central venous catheters were inserted and pressures were monitored if the patients developed shock or had volume overload.
Statistical methods. We entered the data into an Excel (Microsoft Corp., Redmond, WA) spreadsheet and calculated the mean and SD values. We performed the statistical analysis using Epi-Info Version 6.0 (USD, Inc., Stone Mountain, GA) software packages. Numerical values are the mean Ϯ SD. Logistic regression was used to calculate relative risks (RRs) and 95% confidence intervals (CIs). We compared categorical variables by using the chi-square test or Fisher's exact test where appropriate. Two-tailed tests were used throughout and a P value Ͻ 0.05 was considered statistically significant.
RESULTS
Baseline characteristics of the study subjects. A total of 5,210 patients with falciparum malaria were admitted to the Bangkok Hospital for Tropical Diseases during the sevenyear period from 1991 to 1997. One hundred twelve (0.02%) of these patients had malarial ARF. There were 89 males and 23 females who ranged in age from 11 to 71 years (mean Ϯ SD age ϭ 30.4 Ϯ 12.5 years). Most (90) of the patients were in the second and third decades of life. The demographic, clinical, and pretreatment laboratory characteristics on admission are shown in Table 2 . As shown in Table 3 , most of the patients had at least one other manifestation of severe malaria other than ARF.
Ninety-three patients (83%) were oliguric, and the mean FIGURE 1. Mean Ϯ SD serum creatinine (CR) and blood urea nitrogen (BUN) levels in 101 patients from the start of hemodialysis to day 28.
Ϯ SD total duration of oliguria was 7.6 Ϯ 6.2 days. The other 19 patients were nonoliguric. Proteinuria (measured by Dipstix; Boehringer Mannheim, Brussels, Belgium) was present in 61 (54.5%) of the patients and 54 (48.2%) had hemoglobinuria. Forty-five (40.2%) of the patients had granular casts in the urine sediment. Hypoalbuminemia was associated with a higher degree of impairment of renal function. Compared with patients with a serum creatinine concentration Ͻ 3 mg/dL, those with a creatinine level Ͼ 3 mg/dL were more likely to have an albumin level Ͻ 3 g/dL (RR ϭ 2.1, 95% CI ϭ 1.1-3.8, P ϭ 0.01). Similarly, patients with a blood urea nitrogen (BUN) level Ͼ 60 mg/dL were more likely to have an albumin concentration Ͻ 3 g/dL (RR ϭ 4.9, 95% CI ϭ 1.6-14.6, P ϭ 0.0001). Patients with serum creatinine concentrations Ͼ 3 mg/dL and BUN levels Ͼ 60 mg/dL had 1.5-fold and 1.3-fold higher risks of having a white blood cell count Ͼ 10 ϫ 10 9 /L, respectively (95% CI ϭ 1.1-2.3, P ϭ 0.01 and 95% CI ϭ 0.9-1.9, P ϭ 0.2).
Interestingly, parasite counts Ͻ 250,000/l were associated with greater degrees of impairment of renal function. Patients with serum creatinine concentrations Ͼ 3 mg/dL and BUN levels Ͼ 60 mg/dL had 1.6-fold and 1.4-fold increased risks of having parasite counts Ͻ 250,000/l, respectively (95% CI ϭ 1.2-2.2, P ϭ 0.0002 and 95% CI ϭ 1.1-1.8, P ϭ 0.004).
Results of hemodialysis and anti-malarial therapy. Hemodialysis treatment was performed in 101 (90.2%) of the patients. The other 11 patients were treated conservatively without dialysis, including the correction of hypovolemia/ hypervolemia, electrolyte and acid-base imbalance, and restriction of a protein diet. 9 In the 101 patients requiring hemodialysis, the mean Ϯ SD number of procedures was 6.5 Ϯ 4.9 (range ϭ 1-27). The mean Ϯ SD period of hemodialysis from the first to the last treatment was 9.7 Ϯ 7.9 days (range ϭ 1-41).
The creatinine and BUN levels from start of hemodialysis and over the following four weeks are shown in Figure 1 . The mean Ϯ SD serum creatinine level on the first day of hemodialysis was 5.1 Ϯ 3.0 mg/dL and the mean Ϯ SD BUN level was 100.2 Ϯ 37.1 mg/dL. The mean Ϯ SD time until the serum creatinine level returned to the normal range (Ͻ 1.5 mg/dL) was 20.1 Ϯ 8.2 days, and the mean Ϯ SD time for BUN levels to return to normal (Ͻ 20 mg/dL) was 19.7 Ϯ 7.3 days. Forty-nine (43.8%) of the patients had normal creatinine levels on day 28 after the start of hemodialysis, while 50 (44.6%) of the patients had normal BUN levels.
All of the oliguric patients who survived had their urine output return to normal levels after hemodialysis treatment. Return of urine output to Ͼ 400 ml/24 hr was reached 9.1 Ϯ 6.7 (mean Ϯ SD) days after start of hemodialysis. Three patients had other complications (pneumothorax, urethral rupture and HIV-related infections) and were transferred to other hospitals for further treatment before reaching normal urine output.
The oliguric patients needed an average of five more hemodialysis treatments than the nonoliguric patients (mean Ϯ SD ϭ 7.2 Ϯ 4.9 versus and 2.4 Ϯ 1.4 hemodialysis treatments, respectively). Compared with nonoliguric subjects, the oliguric patients had an eight-fold higher risk of requiring six or more hemodialysis treatments (95% CI ϭ 1.2-53.9, P ϭ 0.0008).
We found no significant differences in the outcome and complications among the different drug regimens of the 112 study patients. The patients had normal liver functions and the livers and spleens were not palpable after treatment. The mean Ϯ SD parasite clearance time was 79.5 Ϯ 31.4 hr (3.3 Ϯ 1.3 days), and the mean Ϯ SD fever clearance time was 163.3 Ϯ 138.5 hr (6.8 Ϯ 5.8 days).
Fatal cases. Overall, 12 patients (10.7%) died at a mean Ϯ SD time of 68.5 Ϯ 72.7 hr after admission (range ϭ 3-183). All of them deteriorated after admission despite being started on treatment. Seven (58.3%) patients died during the first 24 hr after admission.
Seventeen of the patients had their first dialysis before the serum creatinine level was greater than 3 mg/dL and one (5.9%) of these patients died. Ninety-five patients had their first dialysis after the serum creatinine concentration was greater than 3 mg/dL or did not receive dialysis, and 11 (11.6%) of these patients died.
Eleven of the patients who died were jaundiced and eight of them had cerebral malaria with a Glasgow Coma Score Յ 8. The causes of death were acute respiratory distress syndrome and pulmonary edema (n ϭ 7), cerebral malaria (n ϭ 4), and massive upper gastrointestinal tract hemorrhage in association with marked thrombocytopenia and prolonged prothrombin time (n ϭ 1). No deaths resulted from uremia or hyperkalemia.
Compared with those without cerebral symptoms, patients with cerebral complications were more likely to die (RR ϭ 3.6, 95% CI ϭ 1.2-11.2, P ϭ 0.03). Acidosis in combination with ARF increased the risk of dying 16.2 times compared with patients without acidosis (95% CI ϭ 3.8-69.4, P ϭ 0.00001). The patients with hyperparasitemia and ARF had a three-fold higher risk of dying compared with patients with parasite counts less than 250,000/l (95% CI ϭ 0.8-10.3, P ϭ 0.07).
DISCUSSION
Acute renal failure is a complication of falciparum malaria that is especially common among adults in Southeast Asia. 10 A number of mechanisms may contribute to the development of this complication. These include sequestration of parasitized red blood cells in the glomerular capillaries, mesangial and endothelial cell proliferative changes, activation of hemostatic mechanisms, stimulation of the immunologic response, and capillary endothelial damage. 11 Increased vascular permeability systemically can lead to disruption of the microcirculation, hemodynamic changes, renal cortical vasoconstriction, and consequent hypoperfusion, resulting in renal ischemia, acute tubular necrosis, and generalized hypercatabolism. [12] [13] [14] [15] [16] Acute renal failure is very rare in African children with severe malaria, but is a common cause of death in adults. 2, 7 In fact, the three most common complications leading to death in adults in Thailand with severe malaria are pulmonary edema, ARF, and sepsis. 17 A fatal outcome is also associated with multiple organ dysfunction and high degrees of parasitemia. 2, 7, 18, 19 Often in a patient with both cerebral symptoms and renal failure, cerebral malaria is diagnosed but the renal aspect of the disease is overlooked. The administration of excessive parenteral fluid to such a patient during the period of unrecognized impaired renal function can easily lead to pulmonary edema and acute water intoxication. 20 Early diagnosis, prompt treatment with antimalarial drugs, and recognition of complications can reduce the mortality rate of severe falciparum malaria. Since ARF frequently predisposes patients to pulmonary edema and sepsis, it is critical that ARF be promptly recognized and aggressively treated by techniques such as dialysis. The type of treatment, whether medical management, or intervention with dialysis (hemodialysis or peritoneal dialysis), depends upon the availability of these treatment options at the facility where the patient is being managed. Hemodialysis appears to be beneficial for ARF associated with malaria, particularly when started earlier in the course of illness. It should be noted that most patients with severe falciparum malaria do not require dialysis. Moderate renal impairment is usually transient and reversible following rehydration and antimalarial treatment. 20 The duration of renal failure varies from a few days to several weeks.
The majority of deaths in this study occurred within a day of starting hemodialysis or even before it was started. The fatal cases also had several other malarial complications apart from ARF, and the combination of these complications with ARF was apparently the cause of death.
Although peritoneal dialysis has been used in the treatment of malarial renal failure, its effectiveness in severe cases is limited because of peritoneal dysfunction and low clearance due to the impaired microcirculation. For this reason hemodialysis is preferred. 9 In Vietnam, Trang and others studied 64 patients with malarial ARF-treated by peritoneal dialysis. 8 All were oliguric and the mortality rate was 19%. The mortality rate in our oliguric patients treated by hemodialysis was 9.7%.
Most of the patients in this study were given artemisinin derivatives, which are antimalarials that may prevent parasite sequestration/cytoadherence. Although these agents can reduce parasitemia by Ͼ 90% within 24 hr of treatment with virtually no side effects, there is a 10-100% rate of recrudescence within 28 days, with the exact rate depending upon the dosage and duration of treatment, and the severity of the disease. 21 The reason for giving both artemisinin and quinine to seven patients was recrudescence after artemisinin in four cases and therapy failure after quinine in three cases.
Renal failure, especially in oliguric and anuric falciparum malaria patients, is catabolic and the BUN level increases more rapidly than the serum creatinine concentration. 22 In oliguric pre-renal failure, urea may be preferentially reabsorbed and this process may also contribute to a disproportion increase in the BUN concentration compared with the creatinine concentration. On the other hand, urea is not reabsorbed in established acute tubular necrosis and the plasma creatinine concentration increases rapidly if there is rhabdomyolysis. In this study, we found that the BUN level is a more quickly reacting predictor of renal dysfunction in patients with malarial ARF than the serum creatinine concentration (Figure 1 ). Despite these considerations, urea production is also altered by food intake, tissue catabolism, and blood within the intestines, and in general the blood urea levels do not reflect the performance of the kidneys as well as do serum creatinine levels. 9 As in a previous report of ARF in malaria in Vietnam, 18 there were more males than females in the present study. A genuine sex difference in susceptibility to renal dysfunction in patients with falciparum malaria is possible. Jaundice is a common feature in malarial renal failure.
Total bilirubin levels Ͼ 20 mg/dL are often associated with severe renal failure. 15 The association of impaired renal function and jaundice may well represent a common pathology. Visceral organ dysfunction presumably results from the sequestration in the microcirculation of red blood cells containing mature forms of the parasite and the local metabolic, ischemic, and toxic effects related to this process. 7 The significant association of high BUN concentrations with low serum albumin levels may also be a reflection of the relationship between malarial ARF and hepatic dysfunction. Renal dysfunction is usually associated with hyperparasitemia. 7 The association between low parasite count and reduced renal function observed in the present study is therefore paradoxical and the reason is unclear. That seven of the patients already had received antimalarial drugs in provincial hospitals before they were sent to this hospital may have contributed to the observation, but most of our patients came directly to the Bangkok Hospital for Tropical Diseases.
The white blood cell count is usually normal in the setting of malaria, but may be increased in severe malaria, and occasionally there is a leukoerythroblastic picture. 23 There is often a slight monocytosis and eosinophilia, with reactive eosinophilia in the weeks following the acute infection. 24 In this study, secondary infections and the severity of the falciparum malaria may be the main reasons for the association between leukocytosis and impaired renal function.
We conclude that hemodialysis is an effective treatment for oliguric and nonoliguric ARF from severe malaria, particularly when initiated early in the course of illness. Oliguric patients requires more hemodialyses than the nonoliguric patients. Severe malarial patients have a higher mortality rate if the ARF is combined with other complications such as cerebral malaria, acidosis, and hyperparasitemia.
